{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:34:18Z","timestamp":1788975258534,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:00:00Z","timestamp":1716076800000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ygyno.2023.05.014","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T13:16:55Z","timestamp":1684502215000},"page":"190-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salom\u00e9 study including 469 patients. A TMRG and GINECO group study"],"prefix":"10.1016","volume":"174","author":[{"given":"Brunhilde","family":"Hanvic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Lecuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Vanacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Narducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Cherifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Floquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina Aida","family":"Angeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Berton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Pomel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Kalbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Provansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault De La Motte","family":"Rouge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Rom\u00e9o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enora","family":"Laas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Morice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Hudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Meriaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Guyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Illac-Vauquelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Selle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Meeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Genestie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Salleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ygyno.2023.05.014_bb0005","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.ejca.2011.08.008","article-title":"Rare cancers are not so rare: The rare cancer burden in Europe","volume":"47","author":"Gatta","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2023.05.014_bb0010","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy001","article-title":"Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"29","author":"Ray-Coquard","year":"2018","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2023.05.014_bb0015","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1200\/JOP.2016.016261","article-title":"Ovarian sex cord-stromal tumors","volume":"12","author":"Schultz","year":"2016","journal-title":"J Oncol Pract."},{"issue":"26","key":"10.1016\/j.ygyno.2023.05.014_bb0020","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1056\/NEJMoa0902542","article-title":"Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary","volume":"360","author":"Shah","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2023.05.014_bb0025","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/his.12747","article-title":"DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study","volume":"68","author":"Goulvent","year":"2016","journal-title":"Histopathology"},{"issue":"27","key":"10.1016\/j.ygyno.2023.05.014_bb0030","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1200\/JCO.18.02419","article-title":"Management of Rare Ovarian Cancer Histologies","volume":"37","author":"Gershenson","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.ygyno.2023.05.014_bb0035","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1200\/JCO.2007.11.1005","article-title":"Management of ovarian stromal cell tumors","volume":"25","author":"Colombo","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.05.014_bb0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3802\/jgo.2011.22.3.188","article-title":"Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study","volume":"22","author":"Lee","year":"2011","journal-title":"J. Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.05.014_bb0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygyno.2017.03.005","article-title":"Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors","volume":"145","author":"Nasioudis","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2023.05.014_bb0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0029-7844(95)00491-2","article-title":"Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin","volume":"87","author":"Gershenson","year":"1996","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.05.014_bb0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ygyno.2005.01.011","article-title":"The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors","volume":"97","author":"Brown","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.05.014_bb0060","series-title":"Guidelines for Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer","volume":"27","author":"National Comprehensive Cancer Network (NCCN)","year":"2022"},{"issue":"6","key":"10.1016\/j.ygyno.2023.05.014_bb0065","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/annonc\/mdx099","article-title":"Networking for ovarian rare tumors: a significant breakthrough improving disease management","volume":"28","author":"Chiannilkulchai","year":"2017","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.05.014_bb0070","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ygyno.2020.02.012","article-title":"The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study","volume":"157","author":"Lenck","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.05.014_bb0075","series-title":"WHO classification of ovarian sex cord-stromal tumors (2020)","author":"Laura Adhikari","year":"2021"},{"issue":"1","key":"10.1016\/j.ygyno.2023.05.014_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"1","key":"10.1016\/j.ygyno.2023.05.014_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2013.10.013","article-title":"Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network","volume":"132","author":"Maillet","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.05.014_bb0090","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ygyno.2022.03.019","article-title":"Potential histological discordance revealed by second review in the national rare gynecological cancer network (TMRG)","volume":"165","author":"Henno","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.05.014_bb0095","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ygyno.2006.08.032","article-title":"Prognostic factors responsible for survival in sex cord stromal tumors of the ovary\u2014an analysis of 376 women","volume":"104","author":"Zhang","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2023.05.014_bb0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ygyno.2016.08.316","article-title":"Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study","volume":"143","author":"Mangili","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.05.014_bb0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13048-018-0396-x","article-title":"Is adjuvant chemotherapy beneficial for patients with FIGO stage IC adult granulosa cell tumor of the ovary?","volume":"11","author":"Wang","year":"2018","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.ygyno.2023.05.014_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gore.2019.04.004","article-title":"Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors","volume":"28","author":"Nasioudis","year":"2019","journal-title":"Gynecol. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ygyno.2023.05.014_bb0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ygyno.2011.12.442","article-title":"Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary","volume":"125","author":"Park","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2023.05.014_bb0120","first-page":"4547892","article-title":"Granulosa Cell Tumor of the Ovary: A Retrospective Study of 31 Cases and a Review of the Literature","volume":"2018","author":"Dridi","year":"2018","journal-title":"Int. J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2023.05.014_bb0125","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1002\/cam4.1447","article-title":"Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort study","volume":"7","author":"Oseledchyk","year":"2018","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.ygyno.2023.05.014_bb0130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2013.04.047","article-title":"Recurrent granulosa cell tumors (GCTs) of the ovary: A MITO-9 retrospective study","volume":"130","author":"Mangili","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2023.05.014_bb0135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ygyno.2021.07.024","article-title":"A phase 2 study of anastrozole in patients with oestrogen receptor and\/progesterone receptor positive recurrent\/metastatic granulosa cell tumours\/sex-cord stromal tumours of the ovary: The PARAGON\/ANZGOG 0903 trial","volume":"163","author":"Banerjee","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2023.05.014_bb0140","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cncr.28421","article-title":"Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: results of a phase 2 trial of the Gynecologic Oncology Group","volume":"120","author":"Brown","year":"2014","journal-title":"Cancer."},{"issue":"12","key":"10.1016\/j.ygyno.2023.05.014_bb0145","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1001\/jamaoncol.2020.4574","article-title":"Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR\/ENGOT-ov7 Randomized Clinical Trial","volume":"6","author":"Ray-Coquard","year":"2020","journal-title":"JAMA Oncol."},{"issue":"16 suppl","key":"10.1016\/j.ygyno.2023.05.014_bb0150","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1200\/JCO.2022.40.16_suppl.5572","article-title":"Potential clinical activity of pembrolizumab monotherapy in ovarian sex cords, rare epithelial carcinoma, and other rare ovarian tumor histotypes: The French AcS\u00e9 pembrolizumab study from Unicancer","volume":"40","author":"Ray-Coquard","year":"2022","journal-title":"JCO."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823002536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825823002536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T20:52:40Z","timestamp":1715806360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825823002536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":30,"alternative-id":["S0090825823002536"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.05.014","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salom\u00e9 study including 469 patients. A TMRG and GINECO group study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2023.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}